Skip to Content

M 373 (Hydroxychloroquine 200 mg)

Pill imprint M 373 has been identified as Hydroxychloroquine sulfate 200 mg.

Hydroxychloroquine is used in the treatment of rheumatoid arthritis; systemic lupus erythematosus; sjogren's syndrome; undifferentiated connective tissue disease; lyme disease, arthritis (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.